Ginkgo Bioworks Holdings, Inc.

NYSE (USD): Ginkgo Bioworks Holdings, Inc. (DNA)

Last Price

8.16

Today's Change

+0.22 (2.77%)

Day's Change

7.75 - 8.32

Trading Volume

889,991

Overview

Market Cap

453 Million

Shares Outstanding

55 Million

Avg Volume

1,443,836

Avg Price (50 Days)

7.67

Avg Price (200 Days)

27.25

PE Ratio

-0.52

EPS

-15.79

Earnings Announcement

11-Nov-2024

Previous Close

7.94

Open

7.99

Day's Range

7.75 - 8.32

Year Range

5.26 - 75.2

Trading Volume

890,224

Price Change Highlight

1 Day Change

2.77%

5 Day Change

-8.00%

1 Month Change

0.87%

3 Month Change

-44.90%

6 Month Change

-76.28%

Ytd Change

-87.78%

1 Year Change

-84.89%

3 Year Change

-98.58%

5 Year Change

-97.98%

10 Year Change

-97.98%

Max Change

-97.98%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment